219 related articles for article (PubMed ID: 30008938)
1. Hub genes and key pathways of non-small lung cancer identified using bioinformatics.
Tang Q; Zhang H; Kong M; Mao X; Cao X
Oncol Lett; 2018 Aug; 16(2):2344-2354. PubMed ID: 30008938
[TBL] [Abstract][Full Text] [Related]
2. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
3. Identification of key candidate tumor biomarkers in non-small-cell lung cancer by
Chen W; Zhu S; Zhang Y; Xiao J; Tian D
Oncol Lett; 2020 Jan; 19(1):1008-1016. PubMed ID: 31897214
[TBL] [Abstract][Full Text] [Related]
4. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
Yu C; Chen F; Jiang J; Zhang H; Zhou M
Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
[TBL] [Abstract][Full Text] [Related]
5. Investigation of differentially expressed genes in nasopharyngeal carcinoma by integrated bioinformatics analysis.
Zou Z; Gan S; Liu S; Li R; Huang J
Oncol Lett; 2019 Jul; 18(1):916-926. PubMed ID: 31289570
[TBL] [Abstract][Full Text] [Related]
6. Identification of key biomarkers and potential molecular mechanisms in lung cancer by bioinformatics analysis.
Li Z; Sang M; Tian Z; Liu Z; Lv J; Zhang F; Shan B
Oncol Lett; 2019 Nov; 18(5):4429-4440. PubMed ID: 31611952
[TBL] [Abstract][Full Text] [Related]
7. Identification of key genes and evaluation of clinical outcomes in lung squamous cell carcinoma using integrated bioinformatics analysis.
Shi Y; Li Y; Yan C; Su H; Ying K
Oncol Lett; 2019 Dec; 18(6):5859-5870. PubMed ID: 31788059
[TBL] [Abstract][Full Text] [Related]
8. Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma.
Chen FF; Zhang SR; Peng H; Chen YZ; Cui XB
Mol Med Rep; 2019 Oct; 20(4):3649-3660. PubMed ID: 31485619
[TBL] [Abstract][Full Text] [Related]
9. Target and Mechanism of the Xihuang Pill Based on Network Pharmacology for Lung Squamous Cell Carcinoma.
Tu H; Li J; Xu W; Wang Z; Wang L
Altern Ther Health Med; 2023 Oct; 29(7):148-154. PubMed ID: 37442189
[TBL] [Abstract][Full Text] [Related]
10. Identification of key candidate genes and biological pathways in bladder cancer.
Gao X; Chen Y; Chen M; Wang S; Wen X; Zhang S
PeerJ; 2018; 6():e6036. PubMed ID: 30533316
[TBL] [Abstract][Full Text] [Related]
11. Identification of differentially expressed genes and biological pathways in bladder cancer.
Tang F; He Z; Lei H; Chen Y; Lu Z; Zeng G; Wang H
Mol Med Rep; 2018 May; 17(5):6425-6434. PubMed ID: 29532898
[TBL] [Abstract][Full Text] [Related]
12. Identification of key pathways and genes in nasopharyngeal carcinoma using bioinformatics analysis.
Zhu HM; Fei Q; Qian LX; Liu BL; He X; Yin L
Oncol Lett; 2019 May; 17(5):4683-4694. PubMed ID: 30988824
[TBL] [Abstract][Full Text] [Related]
13. Survival-based bioinformatics analysis to identify hub genes and key pathways in non-small cell lung cancer.
Liu C; Chen Y; Deng Y; Dong Y; Jiang J; Chen S; Kang W; Deng J; Sun H
Transl Cancer Res; 2019 Aug; 8(4):1188-1198. PubMed ID: 35116861
[TBL] [Abstract][Full Text] [Related]
14. Identification of key genes and pathways in meningioma by bioinformatics analysis.
Dai J; Ma Y; Chu S; Le N; Cao J; Wang Y
Oncol Lett; 2018 Jun; 15(6):8245-8252. PubMed ID: 29805558
[TBL] [Abstract][Full Text] [Related]
15. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis.
Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB
Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743
[TBL] [Abstract][Full Text] [Related]
16. The identification of hub biomarkers and pathways in lung cancer and prognostic evaluation.
Yin Y; Li D; He M; Wang J
Transl Cancer Res; 2022 Aug; 11(8):2622-2635. PubMed ID: 36093542
[TBL] [Abstract][Full Text] [Related]
17. Identification of key differentially expressed mRNAs and microRNAs in non-small cell lung cancer using bioinformatics analysis.
Wang W; Wang S; Pan L
Exp Ther Med; 2020 Oct; 20(4):3720-3732. PubMed ID: 32855723
[TBL] [Abstract][Full Text] [Related]
18. Identification of genes and pathways leading to poor prognosis of non-small cell lung cancer using integrated bioinformatics analysis.
Cui S; Lou S; Feng J; Tang X; Xiao X; Huang R; Guo W; Zhou Y; Huang F
Transl Cancer Res; 2022 Apr; 11(4):710-724. PubMed ID: 35571642
[TBL] [Abstract][Full Text] [Related]
19. Microarray based analysis of gene regulation by mesenchymal stem cells in breast cancer.
Zhang M; Gao CE; Li WH; Yang Y; Chang L; Dong J; Ren YX; Chen D
Oncol Lett; 2017 Apr; 13(4):2770-2776. PubMed ID: 28454465
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics analysis and experimental validation of differentially expressed genes in mouse articular chondrocytes treated with IL-1β using microarray data.
Liang F; Peng L; Ma YG; Hu W; Zhang WB; Deng M; Li YM
Exp Ther Med; 2022 Jan; 23(1):6. PubMed ID: 34815758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
